<< Cardiogenesis sponsors educational symposium on refractory angina treatment method | How the human brain processes incoming sensory signals amidst background noise >>

Phase II study of OPAXIO to be revealed

Published on September 24, 2009 at 5:11 AM · No Comments

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

Source: http://www.celltherapeutics.com

1c4eea10-c582-4656-a139-4281007c7d0b|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Cancer, Cell, Cisplatin, Esophageal Cancer, Oncology, Paclitaxel

Women with breast cancer do not benefit from flaxseedFlaxseed provides no benefit in easing hot flashes among breast cancer patients and postmenopausal w...
International Phase II trial to study LY2181308 efficacy in patients with lung cancerCancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer pati...
Researchers find a new way to tackle colon cancerOne difficulty with fighting cancer cells is that they are similar in many respects to the body's st...
Gallbladder emptying in primary sclerosing cholangitis patientsPrimary sclerosing cholangitis (PSC) is an idiopathic chronic cholestatic inflammatory liver disease...
Lung cancer: Molecular scissors determine therapy effectivenessIn the past few years, a number of anti-cancer drugs have been developed which are directed selectiv...
Phenoxodiol - docetaxel combination for women with recurrent ovarian cancerA clinical study of ovarian cancer initiated by investigators at Yale School of Medicine will combin...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.